Does TAFAMIDIS Cause Product dose omission issue? 215 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Product dose omission issue have been filed in association with TAFAMIDIS (Vyndamax). This represents 2.3% of all adverse event reports for TAFAMIDIS.
215
Reports of Product dose omission issue with TAFAMIDIS
2.3%
of all TAFAMIDIS reports
43
Deaths
97
Hospitalizations
How Dangerous Is Product dose omission issue From TAFAMIDIS?
Of the 215 reports, 43 (20.0%) resulted in death, 97 (45.1%) required hospitalization, and 2 (0.9%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does TAFAMIDIS Cause?
Death (2,553)
Dyspnoea (608)
Off label use (571)
Cardiac failure (444)
Fatigue (438)
Fall (372)
Malaise (301)
Hypoacusis (298)
Atrial fibrillation (296)
Asthenia (256)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TAFAMIDIS Alternatives Have Lower Product dose omission issue Risk?
TAFAMIDIS vs TAFAMIDIS MEGLUMINE
TAFAMIDIS vs TAFASITAMAB
TAFAMIDIS vs TAFASITAMAB-CXIX
TAFAMIDIS vs TAFINLAR
TAFAMIDIS vs TAFLUPROST